Table 2. Clinical Outcomes through 7-Year.
| Number of patients with event (Cumulative Incidence) | ||
|---|---|---|
| SES stratum | BMS stratum | |
| N = 5078 | N = 5392 | |
| Death | 847 (23.7%) | 1064 (25.8%) |
| Cardiac | 364 (10.5%) | 515 (11.9%) |
| Non-cardiac | 483 (14.7%) | 549 (15.9%) |
| All MI | 341 (9.0%) | 372 (9.1%) |
| MI excluding non-Q MI within 7 days | 213 (6.5%) | 268 (7.0%) |
| Spontaneous MI | 83 (3.1%) | 128 (3.8%) |
| Definite ST | 73 (1.8%) | 108 (2.5%) |
| All Stroke | 334 (9.2%) | 309 (7.8%) |
| Hemorrhagic stroke | 91 (2.7%) | 61 (1.9%) |
| Ischemic stroke | 253 (6.8%) | 251 (6.0%) |
| GUSTO severe bleeding | 243 (6.5%) | 251 (6.6%) |
The cumulative incidences were calculated by Kaplan-Meier method.
GUSTO = global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries, MI = myocardial infarction, and ST = stent thrombosis.